Los Angeles, CA, United States of America

Patrcik G Harran

This inventor holds 2 USPTO granted patents. Top assignee: The University of Texas System. Active years: 2011-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrcik G Harran. Retrieved from https://idiyas.com/inventor/patrcik-g-harran

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Patrcik G Harran

Introduction

Patrcik G Harran is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of biochemistry, particularly in the development of small molecule inhibitors. With a total of 2 patents, Harran's work focuses on innovative methods to inhibit ghrelin O-acyltransferase (GOAT).

Latest Patents

Harran's latest patents involve the design of small molecules that inhibit ghrelin O-acyltransferase. The first patent describes methods that comprise contacting GOAT with an inhibitor and detecting the resultant inhibition. The second patent reiterates this innovative approach, emphasizing the potential applications of these small molecule inhibitors in therapeutic settings.

Career Highlights

Patrcik G Harran is affiliated with the University of Texas System, where he continues to advance research in his field. His work has garnered attention for its potential impact on metabolic disorders and obesity treatment.

Collaborations

Harran has collaborated with esteemed colleagues, including Michael S Brown and Joseph L Goldstein. These partnerships have further enriched his research and contributed to the advancement of knowledge in biochemistry.

Conclusion

Patrcik G Harran's contributions to the field of biochemistry through his innovative patents highlight the importance of research in developing new therapeutic strategies. His work continues to inspire future innovations in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…